Symbol:
Scn2a
Name:
sodium voltage-gated channel alpha subunit 2
RGD ID:
3632
Description:
Enables leucine zipper domain binding activity; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; and voltage-gated sodium channel activity. Involved in several processes, including cellular response to hypoxia; nervous system development; and neuronal action potential. Located in axon initial segment; node of Ranvier; and plasma membrane. Part of voltage-gated sodium channel complex. Human ortholog(s) of this gene implicated in benign familial infantile seizures 3; developmental and epileptic encephalopathy 11; and episodic ataxia type 9. Orthologous to human SCN2A (sodium voltage-gated channel alpha subunit 2); INTERACTS WITH 1-naphthyl isothiocyanate; 2,2',4,4'-Tetrabromodiphenyl ether; 2,2',5,5'-tetrachlorobiphenyl.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
alternative product; NachII; Nav1.2; RII/RIIA; RIIA sodium channel protein; RNSCPIIR; SCN; Scn2a1; Scn2a2; ScpII; sodium channel protein brain II subunit alpha; sodium channel protein type 2 subunit alpha; sodium channel protein type II subunit alpha; sodium channel protein, brain II subunit alpha; Sodium channel voltage-gated type II alpha polypeptide; sodium channel, voltage-gated, type 2, alpha 1 polypeptide; sodium channel, voltage-gated, type 2, alpha 1 subunit; sodium channel, voltage-gated, type II, alpha 1; Sodium channel, voltage-gated, type II, alpha polypeptide; sodium channel, voltage-gated, type II, alpha subunit; voltage-gated sodium channel subunit alpha Nav1.2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SCN2A (sodium voltage-gated channel alpha subunit 2)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Scn2a (sodium channel, voltage-gated, type II, alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Scn2a (sodium voltage-gated channel alpha subunit 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SCN2A (sodium voltage-gated channel alpha subunit 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SCN2A (sodium voltage-gated channel alpha subunit 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Scn2a (sodium voltage-gated channel alpha subunit 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SCN2A (sodium voltage-gated channel alpha subunit 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
SCN2A (sodium voltage-gated channel alpha subunit 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
SCN4A (sodium voltage-gated channel alpha subunit 4)
HGNC
OrthoDB
Homo sapiens (human):
RPL37 (ribosomal protein L37)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
SCN2A (sodium voltage-gated channel alpha subunit 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Scn2a (sodium channel, voltage-gated, type II, alpha)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
scn1lab (sodium channel, voltage-gated, type I like, alpha b)
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
CCH1
Alliance
DIOPT (Hieranoid|InParanoid|SonicParanoid)
Drosophila melanogaster (fruit fly):
para
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
scn1a
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
scn3a
Alliance
DIOPT (OrthoFinder|OrthoInspector|PANTHER)
Allele / Splice:
Scn2aem1Mcwi
Scn2aem2Mcwi
Genetic Models:
LE-Scn2aem2Mcwi
LE-Scn2aem1Mcwi
Is Marker For:
QTLs:
BpQTLcluster4
Tsu1
Hrtrt17
Candidate Gene For:
Cia11 Hrtrt17
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 70,710,862 - 70,845,569 (+) NCBI GRCr8 mRatBN7.2 3 50,302,781 - 50,437,504 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 50,302,877 - 50,437,214 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 53,646,466 - 53,788,492 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 62,230,075 - 62,372,108 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 60,013,503 - 60,148,019 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 51,687,910 - 51,822,008 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 51,687,809 - 51,822,250 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 58,322,640 - 58,456,658 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 47,588,413 - 47,722,800 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 47,484,784 - 47,619,172 (+) NCBI Celera 3 49,896,043 - 50,030,402 (+) NCBI Celera RH 3.4 Map 3 613.5 RGD Cytogenetic Map 3 q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Scn2a Rat (+)-catechin multiple interactions ISO SCN2A (Homo sapiens) 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of SCN2A mRNA CTD PMID:24763279 Scn2a Rat 1,2-dimethylhydrazine decreases expression ISO Scn2a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SCN2A mRNA CTD PMID:22206623 Scn2a Rat 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SCN2A mRNA CTD PMID:30723492 Scn2a Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Scn2a (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Scn2a Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 Scn2a Rat 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 Scn2a Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Scn2a (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Scn2a Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Scn2a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SCN2A mRNA CTD PMID:21354282 Scn2a Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SCN2A mRNA CTD PMID:33387578 Scn2a Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SCN2A mRNA CTD PMID:32109520 Scn2a Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Scn2a Rat 2-methylcholine affects expression ISO SCN2A (Homo sapiens) 6480464 beta-methylcholine affects the expression of SCN2A mRNA CTD PMID:21179406 Scn2a Rat 3',5'-cyclic AMP multiple interactions ISO SCN2A (Homo sapiens) 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of SCN2A mRNA CTD PMID:33713149 Scn2a Rat 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions EXP 6480464 4 more ... CTD PMID:26917740 Scn2a Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SCN2A mRNA CTD PMID:24780913 Scn2a Rat aflatoxin B1 decreases methylation ISO SCN2A (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SCN2A gene CTD PMID:27153756 Scn2a Rat all-trans-retinoic acid multiple interactions ISO SCN2A (Homo sapiens) 6480464 [Tretinoin co-treated with Phenylbutyrates co-treated with 1-hydroxy-2-oxo-3 more ... CTD PMID:23284745 and PMID:26655721 Scn2a Rat all-trans-retinoic acid increases expression ISO SCN2A (Homo sapiens) 6480464 Tretinoin results in increased expression of SCN2A mRNA CTD PMID:26655721 Scn2a Rat arsenous acid increases expression ISO SCN2A (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SCN2A mRNA CTD PMID:26705709 Scn2a Rat atrazine decreases expression ISO SCN2A (Homo sapiens) 6480464 Atrazine results in decreased expression of SCN2A mRNA CTD PMID:22378314 Scn2a Rat benzo[a]pyrene increases methylation ISO SCN2A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SCN2A 5' UTR CTD PMID:27901495 Scn2a Rat benzo[a]pyrene increases expression ISO SCN2A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SCN2A mRNA CTD PMID:32234424 Scn2a Rat bis(2-ethylhexyl) phthalate decreases expression ISO Scn2a (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of SCN2A mRNA CTD PMID:19850644 Scn2a Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Scn2a (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SCN2A mRNA] CTD PMID:19850644 Scn2a Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SCN2A mRNA CTD PMID:25181051 Scn2a Rat bisphenol A decreases expression ISO Scn2a (Mus musculus) 6480464 bisphenol A results in decreased expression of SCN2A mRNA CTD PMID:32156529 Scn2a Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SCN2A gene CTD PMID:28505145 Scn2a Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SCN2A mRNA CTD PMID:33453195 Scn2a Rat cannabidiol decreases activity ISO SCN2A (Homo sapiens) 6480464 Cannabidiol results in decreased activity of SCN2A protein CTD PMID:30219789 Scn2a Rat CGP 52608 multiple interactions ISO SCN2A (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SCN2A gene] CTD PMID:28238834 Scn2a Rat CHIR 99021 multiple interactions ISO SCN2A (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mRNA CTD PMID:34480604 Scn2a Rat cisplatin multiple interactions ISO SCN2A (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SCN2A mRNA CTD PMID:27392435 Scn2a Rat cyclosporin A increases methylation ISO SCN2A (Homo sapiens) 6480464 Cyclosporine results in increased methylation of SCN2A promoter CTD PMID:27989131 Scn2a Rat cyfluthrin multiple interactions EXP 6480464 cyfluthrin affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium] CTD PMID:18538810 Scn2a Rat cypermethrin affects binding EXP 6480464 cypermethrin binds to SCN2A protein CTD PMID:9863771 Scn2a Rat cypermethrin multiple interactions EXP 6480464 cypermethrin affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium] and SCN1B protein promotes the reaction [cypermethrin binds to SCN2A protein] CTD PMID:18538810 and PMID:9863771 Scn2a Rat diarsenic trioxide increases expression ISO SCN2A (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SCN2A mRNA CTD PMID:26705709 Scn2a Rat diazinon affects expression EXP 6480464 Diazinon affects the expression of SCN2A mRNA CTD PMID:22546817 Scn2a Rat dieldrin affects expression EXP 6480464 Dieldrin affects the expression of SCN2A mRNA CTD PMID:22546817 Scn2a Rat dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of SCN2A mRNA CTD PMID:16122865 Scn2a Rat dorsomorphin multiple interactions ISO SCN2A (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Scn2a Rat ethanol increases expression ISO Scn2a (Mus musculus) 6480464 Ethanol results in increased expression of SCN2A mRNA CTD PMID:30319688 Scn2a Rat fenpropathrin multiple interactions EXP 6480464 fenpropathrin affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium] CTD PMID:18538810 Scn2a Rat fenvalerate multiple interactions EXP 6480464 fenvalerate affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium] CTD PMID:18538810 Scn2a Rat genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of SCN2A mRNA CTD PMID:21782745 Scn2a Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SCN2A mRNA CTD PMID:33387578 Scn2a Rat L-ascorbic acid multiple interactions ISO SCN2A (Homo sapiens) 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mRNA and [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of SCN2A mRNA CTD PMID:33713149 and PMID:34480604 Scn2a Rat L-ascorbic acid 2-phosphate multiple interactions ISO SCN2A (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mRNA CTD PMID:34480604 Scn2a Rat lamotrigine decreases activity ISO SCN2A (Homo sapiens) 6480464 lamotrigine results in decreased activity of SCN2A protein CTD PMID:11212204 Scn2a Rat lead(0) affects expression ISO SCN2A (Homo sapiens) 6480464 Lead affects the expression of SCN2A mRNA CTD PMID:28903495 Scn2a Rat maneb multiple interactions ISO Scn2a (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of SCN2A mRNA CTD PMID:36117858 Scn2a Rat mercury dibromide increases expression ISO SCN2A (Homo sapiens) 6480464 mercuric bromide results in increased expression of SCN2A mRNA CTD PMID:26272509 Scn2a Rat mercury dibromide multiple interactions ISO SCN2A (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCN2A mRNA CTD PMID:27188386 Scn2a Rat methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of SCN2A mRNA CTD PMID:21782745 Scn2a Rat nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of SCN2A mRNA CTD PMID:22546817 Scn2a Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SCN2A mRNA CTD PMID:33387578 Scn2a Rat paraquat multiple interactions ISO Scn2a (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of SCN2A mRNA CTD PMID:36117858 Scn2a Rat PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23829299 Scn2a Rat PCB138 multiple interactions ISO Scn2a (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Scn2a Rat phenylmercury acetate increases expression ISO SCN2A (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of SCN2A mRNA CTD PMID:26272509 Scn2a Rat phenylmercury acetate multiple interactions ISO SCN2A (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCN2A mRNA CTD PMID:27188386 Scn2a Rat phenytoin decreases activity ISO SCN2A (Homo sapiens) 6480464 Phenytoin results in decreased activity of SCN2A protein CTD PMID:11212204 Scn2a Rat pinostrobin increases phosphorylation ISO SCN2A (Homo sapiens) 6480464 pinostrobin results in increased phosphorylation of SCN2A protein CTD PMID:37164308 Scn2a Rat pioglitazone multiple interactions ISO Scn2a (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SCN2A mRNA CTD PMID:27935865 Scn2a Rat pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SCN2A mRNA CTD PMID:12832660 Scn2a Rat SB 431542 multiple interactions ISO SCN2A (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:34480604 Scn2a Rat silicon dioxide decreases expression ISO SCN2A (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of SCN2A mRNA CTD PMID:34973136 Scn2a Rat sodium arsenite affects methylation ISO SCN2A (Homo sapiens) 6480464 sodium arsenite affects the methylation of SCN2A gene CTD PMID:28589171 Scn2a Rat sodium arsenite decreases expression ISO Scn2a (Mus musculus) 6480464 sodium arsenite results in decreased expression of SCN2A mRNA CTD PMID:36209798 and PMID:37682722 Scn2a Rat sodium atom multiple interactions EXP 6480464 2 more ... CTD PMID:18538810 more ... Scn2a Rat sodium atom increases transport EXP 6480464 SCN2A protein mutant form results in increased transport of Sodium and SCN2A protein results in increased transport of Sodium CTD PMID:19442819 Scn2a Rat temozolomide decreases expression ISO SCN2A (Homo sapiens) 6480464 Temozolomide results in decreased expression of SCN2A mRNA CTD PMID:31758290 Scn2a Rat tetrodotoxin multiple interactions EXP 6480464 Tetrodotoxin results in decreased activity of [SCN2A protein binds to SCN1B protein] CTD PMID:9236205 Scn2a Rat tetrodotoxin decreases activity EXP 6480464 Tetrodotoxin results in decreased activity of SCN2A protein CTD PMID:22972919 Scn2a Rat tetrodotoxin multiple interactions ISO SCN2A (Homo sapiens) 6480464 Tetrodotoxin inhibits the reaction [decamethrin results in decreased expression of SCN2A mRNA] CTD PMID:25358543 Scn2a Rat thapsigargin multiple interactions ISO SCN2A (Homo sapiens) 6480464 4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in increased expression of SCN2A mRNA] CTD PMID:19442820 Scn2a Rat thapsigargin increases expression ISO SCN2A (Homo sapiens) 6480464 Thapsigargin results in increased expression of SCN2A mRNA CTD PMID:19442820 Scn2a Rat tris(2-butoxyethyl) phosphate affects expression ISO SCN2A (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of SCN2A mRNA CTD PMID:29024780 Scn2a Rat valproic acid increases expression ISO SCN2A (Homo sapiens) 6480464 Valproic Acid results in increased expression of SCN2A mRNA CTD PMID:19101580 and PMID:26705709 Scn2a Rat XAV939 multiple interactions ISO SCN2A (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mRNA CTD PMID:34480604
(+)-catechin (ISO) 1,2-dimethylhydrazine (ISO) 1-naphthyl isothiocyanate (EXP) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (EXP) 2,2',5,5'-tetrachlorobiphenyl (EXP,ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2-methylcholine (ISO) 3',5'-cyclic AMP (ISO) 4,5,6,7-TETRABROMOBENZOTRIAZOLE (EXP) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) arsenous acid (ISO) atrazine (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) cadmium dichloride (EXP) cannabidiol (ISO) CGP 52608 (ISO) CHIR 99021 (ISO) cisplatin (ISO) cyclosporin A (ISO) cyfluthrin (EXP) cypermethrin (EXP) diarsenic trioxide (ISO) diazinon (EXP) dieldrin (EXP) dimethylarsinic acid (EXP) dorsomorphin (ISO) ethanol (ISO) fenpropathrin (EXP) fenvalerate (EXP) genistein (EXP) gentamycin (EXP) L-ascorbic acid (ISO) L-ascorbic acid 2-phosphate (ISO) lamotrigine (ISO) lead(0) (ISO) maneb (ISO) mercury dibromide (ISO) methoxychlor (EXP) nickel dichloride (EXP) paracetamol (EXP) paraquat (ISO) PCB138 (EXP,ISO) phenylmercury acetate (ISO) phenytoin (ISO) pinostrobin (ISO) pioglitazone (ISO) pirinixic acid (EXP) SB 431542 (ISO) silicon dioxide (ISO) sodium arsenite (ISO) sodium atom (EXP) temozolomide (ISO) tetrodotoxin (EXP,ISO) thapsigargin (ISO) tris(2-butoxyethyl) phosphate (ISO) valproic acid (ISO) XAV939 (ISO)
Biological Process
axon development (IEP) cellular response to hypoxia (IDA) cerebral cortex development (IEP) corpus callosum development (IEP) dentate gyrus development (ISO) determination of adult lifespan (ISO) intrinsic apoptotic signaling pathway in response to osmotic stress (ISO,ISS) membrane depolarization during action potential (IBA) memory (ISO,ISS) monoatomic cation transmembrane transport (IEA) monoatomic ion transmembrane transport (IEA) monoatomic ion transport (IEA) myelination (IEP) nerve development (ISO) nervous system development (ISO,ISS) neuron apoptotic process (ISO,ISS) neuronal action potential (IBA,IDA,IEA,ISO,TAS) optic nerve development (IEP) regulation of presynaptic membrane potential (IEA) sodium ion transmembrane transport (IDA,IEA,ISO) sodium ion transport (IDA,IEA,ISO) transmembrane transport (IEA)
1.
Interaction of the Nav1.2a subunit of the voltage-dependent sodium channel with nodal ankyrinG. In vitro mapping of the interacting domains and association in synaptosomes.
Bouzidi M, etal., J Biol Chem 2002 Aug 9;277(32):28996-9004.
2.
Structural and energetic determinants of apo calmodulin binding to the IQ motif of the Na(V)1.2 voltage-dependent sodium channel.
Feldkamp MD, etal., Structure. 2011 May 11;19(5):733-47. doi: 10.1016/j.str.2011.02.009.
3.
Dopamine modulation of neuronal Na(+) channels requires binding of A kinase-anchoring protein 15 and PKA by a modified leucine zipper motif.
Few WP, etal., Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5187-92. Epub 2007 Mar 14.
4.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
5.
Crystallographic insights into sodium-channel modulation by the beta4 subunit.
Gilchrist J, etal., Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E5016-24. doi: 10.1073/pnas.1314557110. Epub 2013 Dec 2.
6.
Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis.
Griffiths MM, etal., Arthritis Rheum 2000 Jun;43(6):1278-89
7.
Coexpression of high-voltage-activated ion channels Kv3.4 and Cav1.2 in pioneer axons during pathfinding in the developing rat forebrain.
Huang CY, etal., J Comp Neurol. 2012 Nov 1;520(16):3650-72. doi: 10.1002/cne.23119.
8.
Autosomal dominant epilepsy with febrile seizures plus with missense mutations of the (Na+)-channel alpha 1 subunit gene, SCN1A.
Ito M, etal., Epilepsy Res 2002 Jan;48(1-2):15-23.
9.
The Nav1.2 channel is regulated by GSK3.
James TF, etal., Biochim Biophys Acta. 2015 Apr;1850(4):832-44. doi: 10.1016/j.bbagen.2015.01.011. Epub 2015 Jan 20.
10.
High-density rat radiation hybrid maps containing over 24,000 SSLPs, genes, and ESTs provide a direct link to the rat genome sequence.
Kwitek AE, etal., Genome Res. 2004 Apr;14(4):750-7
11.
Helix-stabilizing effects of the pentapeptide KIFMK and its related peptides on the sodium channel inactivation gate peptides.
Maeda Y, etal., J Pept Res 2001 Nov;58(5):413-23.
12.
Molecular diversity of voltage-gated sodium channel alpha subunits expressed in neuronal and non-neuronal excitable cells.
Mechaly I, etal., Neuroscience. 2005;130(2):389-96.
13.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
14.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
15.
Structure and function of sodium channel.
Noda M and Numa S, J Recept Res 1987;7(1-4):467-97.
16.
Structure and function of sodium channel.
Noda M and Numa S, J Recept Res 1987;7(1-4):467-97.
17.
Existence of distinct sodium channel messenger RNAs in rat brain.
Noda M, etal., Nature 1986 Mar 13-19;320(6058):188-92.
18.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
19.
SUMOylation of NaV1.2 channels mediates the early response to acute hypoxia in central neurons.
Plant LD, etal., Elife. 2016 Dec 28;5. doi: 10.7554/eLife.20054.
20.
Sodium currents in medullary neurons isolated from the pre-Botzinger complex region.
Ptak K, etal., J Neurosci. 2005 May 25;25(21):5159-70.
21.
GOA pipeline
RGD automated data pipeline
22.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
23.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
24.
Direct interaction between synaptotagmin and the intracellular loop I-II of neuronal voltage-sensitive sodium channels.
Sampo B, etal., Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3666-71.
25.
Early events in node of Ranvier formation during myelination and remyelination in the PNS.
Schafer DP, etal., Neuron Glia Biol. 2006 May;2(2):69-79.
26.
A novel SCN2A mutation in family with benign familial infantile seizures.
Striano P, etal., Epilepsia. 2006 Jan;47(1):218-20.
27.
Gene-based anchoring of the rat genetic linkage and cytogenetic maps: new regional localizations, orientation of the linkage groups, and insights into mammalian chromosome evolution.
Szpirer C, etal., Mamm Genome 1998 Sep;9(9):721-34
Scn2a (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 70,710,862 - 70,845,569 (+) NCBI GRCr8 mRatBN7.2 3 50,302,781 - 50,437,504 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 50,302,877 - 50,437,214 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 53,646,466 - 53,788,492 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 62,230,075 - 62,372,108 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 60,013,503 - 60,148,019 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 51,687,910 - 51,822,008 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 51,687,809 - 51,822,250 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 58,322,640 - 58,456,658 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 47,588,413 - 47,722,800 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 47,484,784 - 47,619,172 (+) NCBI Celera 3 49,896,043 - 50,030,402 (+) NCBI Celera RH 3.4 Map 3 613.5 RGD Cytogenetic Map 3 q21 NCBI
SCN2A (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 2 165,239,414 - 165,392,304 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 2 165,194,993 - 165,392,310 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 2 166,095,924 - 166,248,814 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 2 165,804,158 - 165,957,066 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 2 165,976,098 - 166,072,046 NCBI Celera 2 159,706,512 - 159,859,384 (+) NCBI Celera Cytogenetic Map 2 q24.3 NCBI HuRef 2 157,978,323 - 158,131,089 (+) NCBI HuRef CHM1_1 2 166,101,845 - 166,254,789 (+) NCBI CHM1_1 T2T-CHM13v2.0 2 165,696,714 - 165,849,575 (+) NCBI T2T-CHM13v2.0
Scn2a (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 2 65,451,108 - 65,597,791 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 2 65,451,115 - 65,597,791 (+) Ensembl GRCm39 Ensembl GRCm38 2 65,620,764 - 65,767,447 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 2 65,620,771 - 65,767,447 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 2 65,508,502 - 65,605,504 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 2 65,471,335 - 65,568,290 (+) NCBI MGSCv36 mm8 Celera 2 67,347,826 - 67,445,379 (+) NCBI Celera Cytogenetic Map 2 C1.3 NCBI cM Map 2 38.61 NCBI
Scn2a (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955449 8,721,784 - 8,846,200 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955449 8,722,043 - 8,846,165 (-) NCBI ChiLan1.0 ChiLan1.0
SCN2A (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 13 67,900,817 - 68,052,848 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 2B 67,915,794 - 68,067,823 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 2B 52,514,918 - 52,667,225 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 2B 169,873,992 - 170,026,392 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 2B 169,928,323 - 170,027,509 (+) Ensembl panpan1.1 panPan2
SCN2A (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 36 10,472,496 - 10,605,055 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 36 10,472,361 - 10,602,685 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 36 10,615,273 - 10,749,736 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 36 10,604,046 - 10,738,882 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 36 10,604,041 - 10,738,874 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 36 10,686,329 - 10,820,763 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 36 10,658,084 - 10,792,902 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 36 10,770,872 - 10,905,712 (+) NCBI UU_Cfam_GSD_1.0
Scn2a (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405303 127,536,296 - 127,745,013 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936469 13,872,701 - 13,971,005 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936469 13,872,701 - 14,019,170 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SCN2A (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 15 71,864,784 - 71,999,211 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 15 71,864,753 - 71,999,219 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 15 80,349,224 - 80,429,339 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SCN2A (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 10 50,717,264 - 50,886,079 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 10 50,717,271 - 50,888,145 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666040 148,625,514 - 148,788,747 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
.
Predicted Target Of
Count of predictions: 92 Count of miRNA genes: 70 Interacting mature miRNAs: 88 Transcripts: ENSRNOT00000007069 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
2298542 Neuinf11 Neuroinflammation QTL 11 3.9 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 3 15005422 76927699 Rat 1358362 Srcrt2 Stress Responsive Cort QTL 2 2.78 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 38192233 133483320 Rat 737818 Hcar12 Hepatocarcinoma resistance QTL 12 2.6 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 3 29463235 118376539 Rat 9590286 Uminl1 Urine mineral level QTL 1 3.5 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 3 28249687 73249687 Rat 10450816 Scl75 Serum cholesterol level QTL 75 4.4 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 38192233 50749747 Rat 724523 Tsu1 Thymus enlargement suppressive QTL 1 3.84 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 3 50437504 115638231 Rat 2313093 Bmd77 Bone mineral density QTL 77 2.2 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 3 27494621 50302886 Rat 1581503 Cm58 Cardiac mass QTL 58 2.7 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 43827364 121056321 Rat 2292613 Ept16 Estrogen-induced pituitary tumorigenesis QTL 16 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat 61356 Bp37 Blood pressure QTL 37 3 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 3 30684642 75684642 Rat 1358905 Hrtrt17 Heart rate QTL 17 5.9 0.000014 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 3 10861912 89878372 Rat 70191 BpQTLcluster4 Blood pressure QTL cluster 4 3 arterial blood pressure trait (VT:2000000) absolute change in systolic blood pressure (CMO:0000607) 3 10778704 50302886 Rat 2313101 Bmd76 Bone mineral density QTL 76 3.6 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 3 27494621 50302886 Rat 8694196 Abfw2 Abdominal fat weight QTL 2 16.58 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 3 28249687 73249687 Rat 2301971 Cm71 Cardiac mass QTL 71 4.63 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 3 41874578 155617519 Rat 1358885 Bp251 Blood pressure QTL 251 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 2301970 Bw81 Body weight QTL 81 5.19 body mass (VT:0001259) body weight (CMO:0000012) 3 41874578 155617519 Rat 2290452 Scl56 Serum cholesterol level QTL 56 2.26 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 3 1 91609953 Rat 12879868 Am6 Aortic mass QTL 6 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 3 31426403 70668733 Rat 11565451 Bw177 Body weight QTL 177 0.002 body mass (VT:0001259) body weight (CMO:0000012) 3 31426403 70668733 Rat 10450852 Stl33 Serum triglyceride level QTL 33 3.4 0.05 blood LDL triglyceride amount (VT:0010699) blood lipoprotein triglyceride level (CMO:0002685) 3 38192233 50749747 Rat 1358888 Bp264 Blood pressure QTL 264 4.43 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 11565452 Kidm57 Kidney mass QTL 57 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 31426403 70668733 Rat 4889975 Bmd81 Bone mineral density QTL 81 4.3 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 3 38710365 50302886 Rat 12879866 Cm94 Cardiac mass QTL 94 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 31426403 70668733 Rat 12879867 Cm95 Cardiac mass QTL 95 0.047 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 3 31426403 70668733 Rat 1300178 Hrtrt4 Heart rate QTL 4 3.74 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 3 43827364 90905114 Rat 2302055 Pia30 Pristane induced arthritis QTL 30 3.5 0.001 blood autoantibody amount (VT:0003725) serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) 3 27936919 72936919 Rat 634317 Bw117 Body weight QTL 117 3.58 abdominal fat pad mass (VT:1000711) abdominal fat pad weight to body weight ratio (CMO:0000095) 3 39454637 53296578 Rat 1331795 Rf30 Renal function QTL 30 3.708 urine potassium amount (VT:0010539) urine potassium level (CMO:0000128) 3 39454637 89115240 Rat 70216 Cm14 Cardiac mass QTL 14 2.1 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 31172320 163586636 Rat 1354589 Bw31 Body weight QTL 31 3.3 body mass (VT:0001259) body weight (CMO:0000012) 3 33703347 78196190 Rat 2303593 Gluco46 Glucose level QTL 46 3 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 28468571 73468571 Rat 1354590 Despr11 Despair related QTL 11 0.000031 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 3 28468571 73468571 Rat 2292591 Esta4 Estrogen-induced thymic atrophy QTL 4 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 3 47233211 147415807 Rat 2313079 Bss73 Bone structure and strength QTL 73 1.5 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 3 27494621 50302886 Rat 1331777 Bw24 Body weight QTL 24 3.503 body mass (VT:0001259) body weight (CMO:0000012) 3 39454637 89115240 Rat 631647 Bp122 Blood pressure QTL 122 6.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 30684642 75684642 Rat 2313076 Bss74 Bone structure and strength QTL 74 2 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 3 27494621 50302886 Rat 1300169 Bp177 Blood pressure QTL 177 2.96 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 3 33703347 61017857 Rat 10450813 Scl74 Serum cholesterol level QTL 74 5.8 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 38192233 50749747 Rat 1559282 Emca5 Estrogen-induced mammary cancer QTL 5 3.9 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 3 43827364 169034231 Rat 2302276 Bw82 Body weight QTL 82 4.32 body mass (VT:0001259) body weight (CMO:0000012) 3 39454637 62951183 Rat 738019 Anxrr10 Anxiety related response QTL 10 3.9 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 3 38517803 83517803 Rat 9590136 Scort3 Serum corticosterone level QTL 3 23.37 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 28249687 73249687 Rat 10450804 Scl70 Serum cholesterol level QTL 70 4.7 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 20714090 65714090 Rat 61419 Cia11 Collagen induced arthritis QTL 11 5.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 3 30356773 98535386 Rat 1354597 Kidm13 Kidney mass QTL 13 2.9 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 3 41874578 104104347 Rat 8552950 Pigfal12 Plasma insulin-like growth factor 1 level QTL 12 7.3 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 3 28249687 73249687 Rat 631676 Cm8 Cardiac mass QTL 8 7.03 0.0001 aorta mass (VT:0002845) aorta weight (CMO:0000076) 3 16954708 61954708 Rat 10450794 Scl69 Serum cholesterol level QTL 69 6.3 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 20714090 65714090 Rat 8694386 Bw159 Body weight QTL 159 4.52 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 3 28249687 73249687 Rat 1354604 Bw36 Body weight QTL 36 2.9 body mass (VT:0001259) body weight (CMO:0000012) 3 33703347 104104347 Rat 631665 Bw8 Body weight QTL 8 5.5 body mass (VT:0001259) body weight (CMO:0000012) 3 50437042 119183768 Rat 2313049 Bss72 Bone structure and strength QTL 72 2.6 0.0001 tibia area (VT:1000281) tibia midshaft cross-sectional area (CMO:0001717) 3 27494621 50302886 Rat 2301400 Cm68 Cardiac mass QTL 68 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 3 31426403 70668733 Rat 1358186 Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat
D3Mit8
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 3 70,710,756 - 70,710,963 (+) Marker Load Pipeline mRatBN7.2 3 50,302,679 - 50,302,886 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,687,711 - 51,687,917 NCBI Rnor6.0 Rnor_5.0 3 58,322,441 - 58,322,647 UniSTS Rnor5.0 RGSC_v3.4 3 47,588,214 - 47,588,420 UniSTS RGSC3.4 RGSC_v3.1 3 47,484,585 - 47,484,792 RGD Celera 3 49,895,844 - 49,896,050 UniSTS RH 3.4 Map 3 615.3 UniSTS RH 3.4 Map 3 615.3 RGD SHRSP x BN Map 3 35.0198 UniSTS SHRSP x BN Map 3 35.0198 RGD FHH x ACI Map 3 36.02 RGD Cytogenetic Map 3 q24 UniSTS
D3Wox9
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 50,436,913 - 50,437,042 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,821,710 - 51,821,836 NCBI Rnor6.0 Rnor_5.0 3 58,456,360 - 58,456,486 UniSTS Rnor5.0 RGSC_v3.4 3 47,722,501 - 47,722,628 RGD RGSC3.4 RGSC_v3.4 3 47,722,502 - 47,722,628 UniSTS RGSC3.4 Celera 3 50,030,104 - 50,030,230 UniSTS Cytogenetic Map 3 q24 UniSTS
D3Wox10
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 50,436,913 - 50,437,041 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,821,710 - 51,821,835 NCBI Rnor6.0 Rnor_5.0 3 58,456,360 - 58,456,485 UniSTS Rnor5.0 RGSC_v3.4 3 47,722,501 - 47,722,627 RGD RGSC3.4 RGSC_v3.4 3 47,722,502 - 47,722,627 UniSTS RGSC3.4 Celera 3 50,030,104 - 50,030,229 UniSTS Cytogenetic Map 3 q24 UniSTS
D3Wox14
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 50,436,785 - 50,437,053 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,821,582 - 51,821,847 NCBI Rnor6.0 Rnor_5.0 3 58,456,232 - 58,456,497 UniSTS Rnor5.0 RGSC_v3.4 3 47,722,374 - 47,722,639 UniSTS RGSC3.4 Celera 3 50,029,976 - 50,030,241 UniSTS Cytogenetic Map 3 q24 UniSTS
D3Arb7
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 3 70,844,979 - 70,845,227 (+) Marker Load Pipeline mRatBN7.2 3 50,436,912 - 50,437,162 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,821,709 - 51,821,956 NCBI Rnor6.0 Rnor_5.0 3 58,456,359 - 58,456,606 UniSTS Rnor5.0 RGSC_v3.4 3 47,722,501 - 47,722,748 UniSTS RGSC3.4 RGSC_v3.4 3 47,722,500 - 47,722,748 RGD RGSC3.4 RGSC_v3.1 3 47,618,872 - 47,619,120 RGD Celera 3 50,030,103 - 50,030,350 UniSTS RH 3.4 Map 3 614.1 RGD RH 3.4 Map 3 614.1 UniSTS RH 2.0 Map 3 405.1 RGD SHRSP x BN Map 3 35.0198 RGD FHH x ACI Map 3 34.98 RGD Cytogenetic Map 3 q24 UniSTS
D3Rat240
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 3 70,752,912 - 70,753,137 (+) Marker Load Pipeline mRatBN7.2 3 50,344,842 - 50,345,069 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,729,860 - 51,730,084 NCBI Rnor6.0 Rnor_5.0 3 58,364,510 - 58,364,734 UniSTS Rnor5.0 RGSC_v3.4 3 47,630,437 - 47,630,661 UniSTS RGSC3.4 RGSC_v3.4 3 47,630,436 - 47,630,661 RGD RGSC3.4 RGSC_v3.1 3 47,526,593 - 47,527,132 RGD Celera 3 49,938,073 - 49,938,297 UniSTS FHH x ACI Map 3 36.02 UniSTS FHH x ACI Map 3 36.02 RGD Cytogenetic Map 3 q24 UniSTS
RH94610
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 50,435,631 - 50,435,801 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,820,428 - 51,820,597 NCBI Rnor6.0 Rnor_5.0 3 58,455,078 - 58,455,247 UniSTS Rnor5.0 RGSC_v3.4 3 47,721,220 - 47,721,389 UniSTS RGSC3.4 Celera 3 50,028,822 - 50,028,991 UniSTS RH 3.4 Map 3 613.5 UniSTS Cytogenetic Map 3 q24 UniSTS
RH138915
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 50,413,356 - 50,413,550 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,798,334 - 51,798,527 NCBI Rnor6.0 Rnor_5.0 3 58,432,984 - 58,433,177 UniSTS Rnor5.0 RGSC_v3.4 3 47,698,945 - 47,699,138 UniSTS RGSC3.4 Celera 3 50,006,547 - 50,006,740 UniSTS RH 3.4 Map 3 619.4 UniSTS Cytogenetic Map 3 q24 UniSTS
Scn1a
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 50,432,608 - 50,433,910 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,817,586 - 51,818,887 NCBI Rnor6.0 Rnor_5.0 3 58,452,236 - 58,453,537 UniSTS Rnor5.0 RGSC_v3.4 3 47,718,197 - 47,719,498 UniSTS RGSC3.4 Celera 3 50,025,799 - 50,027,100 UniSTS Cytogenetic Map 3 q21 UniSTS Cytogenetic Map 3 q24 UniSTS
Scn3a
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 50,432,608 - 50,433,887 (+) MAPPER mRatBN7.2 Rnor_6.0 3 51,817,586 - 51,818,864 NCBI Rnor6.0 Rnor_5.0 3 58,452,236 - 58,453,514 UniSTS Rnor5.0 RGSC_v3.4 3 47,718,197 - 47,719,475 UniSTS RGSC3.4 Celera 3 50,025,799 - 50,027,077 UniSTS Cytogenetic Map 7 q36 UniSTS Cytogenetic Map 3 q21 UniSTS Cytogenetic Map 8 q32 UniSTS Cytogenetic Map 3 q24 UniSTS
This gene Scn2a is modified in the following models/strains:
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
10
49
113
67
66
35
25
35
6
192
96
93
44
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000007069 ⟹ ENSRNOP00000007069
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 50,302,877 - 50,434,883 (+) Ensembl Rnor_6.0 Ensembl 3 51,737,904 - 51,819,679 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000087242 ⟹ ENSRNOP00000072059
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 50,302,877 - 50,437,214 (+) Ensembl Rnor_6.0 Ensembl 3 51,687,809 - 51,822,250 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000098856 ⟹ ENSRNOP00000076431
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 50,302,877 - 50,437,214 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000108259 ⟹ ENSRNOP00000095098
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 50,302,877 - 50,437,214 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000118742 ⟹ ENSRNOP00000087779
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 50,302,877 - 50,435,212 (+) Ensembl
RefSeq Acc Id:
NM_012647 ⟹ NP_036779
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 70,710,956 - 70,845,279 (+) NCBI mRatBN7.2 3 50,302,879 - 50,437,214 (+) NCBI Rnor_6.0 3 51,687,910 - 51,822,008 (+) NCBI Rnor_5.0 3 58,322,640 - 58,456,658 (+) NCBI RGSC_v3.4 3 47,588,413 - 47,722,800 (+) RGD Celera 3 49,896,043 - 50,030,402 (+) RGD
Sequence:
ACCCCCTGTCTTTGCTTTTCCTCTTTAGTAAGGATATTATTGCACATGTGAGATTTTTACTTCCTACTGTAGGCTGAATTCTAGAAACCTGCACTGGAGACTGCTACATTCAACACGCACATGGATTC TGTGCTATGATTACCATTCCTTTTATTTCAGCACTTTCTTACGCGAGGAGCTAAACAGTGACTAAAGAAGCAGGATGAAAAGATGGCACGGTCAGTGCTGGTACCTCCAGGACCTGACAGCTTCCGCT TCTTTACCAGGGAATCCCTTGCTGCTATCGAACAGCGCATTGCAGAAGAGAAAGCTAAGAGACCCAAACAGGAACGCAAGGACGAAGACGATGAAAATGGCCCAAAGCCAAATAGTGACTTGGAAGCA GGAAAATCCCTTCCTTTTATTTATGGAGACATTCCTCCAGAGATGGTGTCAGAACCACTGGAGGACCTGGACCCCTACTATATCAATAAGAAAACCTTTATAGTATTGAATAAGGGGAAAGCAATCTC GCGGTTCAGCGCCACCTCTGCCCTGTACATTTTAACTCCCTTCAACCCCATTAGAAAATTAGCTATTAAGATTTTGGTACATTCTTTATTCAATGTGCTTATCATGTGCACAATTCTTACCAACTGTG TGTTTATGACCATGAGTAACCCTCCAGACTGGACAAAGAATGTGGAGTATACTTTTACAGGAATTTATACTTTTGAATCACTTATTAAAATCCTTGCAAGGGGCTTTTGTCTAGAAGATTTCACATTT CTACGGAATCCCTGGAATTGGTTGGATTTCACAGTCATTACTTTTGCGTATGTAACAGAATTTGTAAACCTAGGCAATGTTTCAGCTCTTCGAACTTTCAGAGTCTTGAGAGCTTTGAAAACTATTTC TGTAATTCCAGGCCTGAAGACTATCGTGGGGGCCCTGATCCAGTCAGTGAAGAAGCTCTCTGACGTCATGATCCTCACCGTGTTCTGTCTCAGTGTCTTTGCTCTAATCGGGCTGCAGCTCTTCATGG GCAACCTGAGGAATAAATGCTTGCAGTGGCCCCCAGACAATTCTACCTTTGAAATAAATATCACTTCCTTCTTTAATAACTCATTGGATTGGAATGGTACTGCCTTCAATAGGACGGTGAACATGTTT AACTGGGACGAATATATTGAAGATAAAAGTCACTTTTATTTTTTGGAAGGACAAAACGATGCTCTGCTTTGTGGGAACAGCTCGGATGCTGGACAGTGTCCAGAAGGATACATCTGTGTGAAGGCTGG GAGAAACCCCAACTACGGCTACACAAGTTTTGACACCTTCAGCTGGGCCTTCTTGTCCTTATTTCGTCTCATGACTCAAGACTTCTGGGAAAACCTTTATCAGCTGACCTTGCGTGCTGCCGGGAAAA CATACATGATATTTTTTGTGCTGGTCATTTTCTTGGGCTCATTCTACCTGATAAATTTGATCCTGGCTGTGGTGGCCATGGCCTACGAGGAACAGAACCAGGCCACACTGGAGGAGGCTGAACAGAAG GAGGCAGAGTTTCAGCAGATGCTGGAGCAACTGAAGAAGCAGCAGGAGGAAGCTCAGGCAGCAGCTGCAGCAGCGTCCGCAGAATCCAGAGACTTCAGCGGGGCAGGCGGGATAGGTGTTTTCTCGGA GAGTTCGTCAGTAGCCTCAAAGTTAAGTTCCAAAAGTGAAAAGGAGTTGAAAAACAGAAGAAAGAAAAAGAAACAGAAAGAACAGGCTGGGGAGGAAGAGAAGGAAGACGCGGTGCGGAAATCTGCCT CTGAGGACAGCATACGAAAGAAAGGCTTCCAGTTTTCCCTGGAAGGAAGTAGATTGACCTACGAGAAGAGATTTTCCTCTCCGCACCAGTCTCTCTTGAGCATCCGAGGCTCCCTATTTTCTCCAAGA CGCAACAGTAGAGCAAGCCTTTTCAACTTCAAAGGTCGAGTGAAGGATATTGGTTCCGAAAATGACTTTGCAGACGATGAACACAGCACATTTGAGGACAACGACAGCAGAAGAGACTCTCTATTTGT ACCACACAGACATGGAGAAAGGCGTCCTAGCAATGTCAGCCAGGCCAGCCGTGCCTCCCGGGGGATACCCACTCTACCCATGAATGGGAAGATGCACAGTGCAGTGGACTGCAACGGTGTGGTGTCCC TGGTTGGAGGCCCCTCTGCGCTCACATCGCCTGTGGGGCAGCTGCTGCCGGAGGGCACAACTACTGAGACAGAAATAAGGAAGAGGAGATCCAGTTCTTACCACGTCTCTATGGACTTGTTGGAAGAC CCTTCAAGGCAAAGGGCAATGAGTATGGCCAGTATTTTGACGAACACTATGGAAGAACTTGAAGAATCCAGACAGAAATGCCCACCCTGCTGGTATAAATTTGCTAATATGTGCCTGATTTGGGACTG TTGTAAGCCATGGCTAAAGGTAAAACACGTTGTCAATCTGGTAGTGATGGATCCATTTGTTGACCTGGCCATCACCATCTGCATTGTGTTAAATACGCTCTTCATGGCCATGGAGCACTACCCCATGA CTGAGCAGTTCAGCAGTGTGCTGTCTGTTGGGAATTTGGTCTTCACTGGGATCTTCACGGCAGAAATGTTTCTCAAGATAATAGCCATGGATCCATATTATTACTTCCAAGAAGGCTGGAATATCTTT GATGGCTTTATAGTGAGCCTTAGTTTAATGGAACTCGGCTTGGCGAATGTGGAAGGATTGTCAGTTCTCCGATCATTCCGGCTGCTTAGAGTCTTCAAGTTGGCAAAGTCCTGGCCCACACTGAACAT GCTCATTAAGATCATCGGCAACTCGGTGGGTGCACTGGGCAACCTGACCCTGGTGCTGGCCATCATCGTCTTCATTTTTGCCGTGGTCGGCATGCAGCTGTTTGGAAAGAGCTACAAGGAGTGTGTCT GTAAGATTTCCAATGATTGTGAGCTCCCGCGCTGGCACATGCACCACTTCTTCCACTCCTTCCTGATCGTGTTTCGAGTCCTGTGTGGGGAGTGGATAGAGACCATGTGGGACTGCATGGAGGTCGCG GGCCAGACCATGTGCCTTACTGTCTTCATGATGGTCATGGTGATTGGGAACCTTGTTGTCCTGAACCTCTTCTTGGCCTTGCTCCTCAGTTCTTTCAGCTCAGACAACCTGGCTGCCACAGATGACGA TAACGAAATGAACAACCTCCAGATAGCCGTGGGAAGGATGCAGAAGGGAATTGATTTTGTTAAAAGGAAGATACGTGAATTCATTCAGAAAGCCTTTGTCAGAAAGCAGAAAGCTTTAGATGAAATCA AACCGCTGGAAGATCTGAATAACAAGAAAGACAGTTGTATCTCCAACCACACGACCATAGAAATAGGCAAGGACCTCAATTACCTCAAAGATGGAAACGGGACGACCAGTGGCATAGGCAGCAGTGTG GAGAAGTATGTGGTAGATGAGAGTGATTACATGTCGTTCATAAACAACCCCAGCCTCACCGTGACTGTGCCCATCGCCCTTGGAGAGTCTGACTTTGAAAACTTAAACACGGAAGAATTCAGTAGTGA GTCAGATATGGAAGAAAGCAAGGAGAAATTGAATGCAACTAGCTCATCTGAGGGCAGTACGGTTGATATAGGCGCTCCGGCAGAGGGAGAGCAGCCAGAGGCCGAACCGGAAGAATCGCTTGAACCGG AAGCGTGTTTCACAGAAGACTGTGTGAGAAAGTTCAAGTGTTGTCAGATAAGCATAGAAGAGGGCAAAGGCAAGCTCTGGTGGAACTTGAGGAAAACGTGCTACAAGATAGTAGAGCATAACTGGTTT GAAACCTTCATCGTTTTTATGATTCTGCTCAGCAGTGGTGCTCTGGCCTTTGAAGACATTTATATTGAGCAGCGAAAGACCATCAAGACCATGCTGGAGTATGCTGACAAGGTTTTCACTTATATCTT CATCCTGGAGATGCTTCTAAAGTGGGTGGCCTATGGTTTCCAAATGTATTTCACCAATGCCTGGTGCTGGCTGGACTTCCTGATCGTTGATGTCTCCTTGGTTAGCTTAACTGCAAATGCCTTGGGCT ATTCGGAACTTGGTGCCATCAAGTCCCTCCGAACGTTAAGAGCTCTGAGACCTCTACGAGCCTTATCCCGATTTGAAGGAATGAGGGTTGTTGTAAACGCTCTCTTAGGCGCCATCCCCTCCATAATG AACGTACTTCTGGTCTGCCTGATCTTTTGGCTAATATTCAGTATCATGGGGGTGAATCTCTTTGCTGGCAAGTTCTACCATTGCATCAACTACACCACGGGGGAAATGTTTGATGTGAGCGTGGTCAA CAACTACAGTGAATGCCAAGCTCTCATTGAGAGCAATCAGACGGCCAGGTGGAAGAACGTGAAGGTCAACTTCGATAACGTGGGACTCGGATACCTTTCTCTGCTCCAAGTAGCCACCTTTAAAGGAT GGATGGATATCATGTATGCAGCTGTTGACTCAAGAAATGTAGAACTGCAGCCCAAATACGAAGACAATCTCTACATGTACCTTTACTTTGTCATCTTCATCATCTTCGGCTCATTCTTCACCCTGAAC CTGTTCATTGGTGTCATCATAGACAACTTCAACCAGCAGAAGAAGAAGTTTGGAGGTCAAGACATCTTTATGACAGAAGAACAGAAGAAATACTACAATGCAATGAAGAAGCTCGGCTCCAAGAAACC GCAGAAGCCCATTCCTCGGCCTGCAAACAAATTTCAAGGGATGGTCTTTGATTTTGTAACCAAACAAGTCTTTGACATCAGCATCATGATCCTCATCTGCCTCAACATGGTGACCATGATGGTGGAAA CGGACGACCAGAGTCAGGAGATGACCAACATCCTGTACTGGATCAACCTGGTGTTCATTGTCCTGTTCACGGGCGAGTGTGTGCTGAAGCTCATCTCCCTCCGCCATTATTATTTCACCATCGGCTGG AATATTTTTGATTTTGTGGTAGTCATCCTCTCCATTGTAGGAATGTTTCTCGCGGAGCTGATAGAGAAGTATTTCGTGTCCCCTACCCTGTTCCGAGTCATCCGCCTGGCCAGGATTGGACGAATCCT ACGCCTGATCAAAGGCGCCAAGGGGATCCGCACTCTGCTCTTTGCTCTGATGATGTCCCTTCCTGCGCTGTTCAACATCGGCCTCCTGCTTTTCCTGGTCATGTTCATCTACGCCATCTTTGGGATGT CCAACTTTGCCTACGTTAAGAGGGAAGTTGGAATTGATGACATGTTCAACTTTGAGACTTTTGGCAACAGCATGATCTGCCTGTTCCAAATCACCACCTCTGCCGGCTGGGACGGACTGCTGGCCCCT ATACTAAATAGCGGACCTCCTGACTGTGACCCTGAAAAAGATCACCCTGGAAGCTCGGTGAAGGGGGACTGTGGGAACCCATCTGTGGGGATTTTCTTTTTTGTCAGCTACATCATCATATCCTTCCT GGTGGTGGTGAACATGTACATCGCTGTCATCCTGGAGAACTTCAGCGTCGCCACCGAAGAAAGTGCAGAGCCTCTGAGTGAGGACGACTTTGAGATGTTCTACGAGGTCTGGGAGAAGTTCGACCCTG ACGCCACTCAGTTCATAGAGTTCTGCAAGCTTTCTGACTTTGCAGCTGCCCTGGATCCTCCCCTCCTCATCGCAAAGCCAAACAAAGTCCAGCTCATTGCCATGGACCTGCCCATGGTGAGTGGAGAC CGCATCCACTGCCTGGACATCTTGTTTGCTTTTACAAAGCGGGTCCTGGGCGAGAGTGGAGAGATGGACGCTCTTCGAATCCAGATGGAAGAAAGGTTCATGGCTTCCAACCCCTCCAAGGTCTCTTA TGAGCCCATTACCACCACCCTGAAACGGAAACAAGAGGAGGTGTCTGCTATTGTCATCCAGCGAGCATACAGGCGGTATCTCCTGAAGCAGAAAGTTAAGAAAGTTTCGTCTATCTATAAAAAAGACA AAGGTAAAGAAGACGAGGGAACGCCCATCAAAGAAGACATCATCACAGATAAACTGAACGAGAATTCAACTCCAGAGAAGACTGATGTGACACCTTCCACAACTTCTCCACCTTCCTACGATAGCGTG ACGAAACCGGAGAAGGAAAAATTTGAAAAGGACAAATCAGAAAAAGAGGACAAAGGGAAAGATATCAGGGAAAGTAAAAAGTAAAAAAATAAAATAATAATAATAATAACGAAAATTAAAAATTAAAA AAAAAGAATATTCCATTTCGTGATCAACTGTTTACAGCCTGTGTTGGTGATGTATCTGTGACTCCCTCAGGAGGTCCATGCCAAACTGACTGTTTCTCTAAGTGTATACTTAAGGTCAGTGCCTATAA CAAGACAGGACCTCGGGTCAGCACACTGGGATTCACCAAACCAGACAAAGAGCACCGACGGGAGGCTTCTATGTTCACAACCAGCTGACACTGCTGAAGAGCGGAGAGCAATGGCTACTCAGACTAGA AGAACATGGAAACGGGGAGGAAAGTTAAATTTTTATGTAAATTTAACATGTGACACTTGATAGCGGTAACTGTCACCACTGTTTGTGTTTTAACTGCCACACCTGCCATATTTTTACAAAATGTGTGC TGTGACTTTATCACTTTTTTTTTTTGATTCACGGGTTGTTTACTCTTATATGTGACTATTTTTGTAAACGGGTTTATGTTCGGGGAGAGGGATTACGGAGGGGATTCGACGTTTCTCTATGTATAACG AGATCTATTTTCAACGAAGGTAATGCTGCAGCTCTCATTCACACACGACGATATCCCATCACACCAGGAAAGAGCTTACTTCTCATTTCAGGATGTTTTTAGATTTTTTGAGGTGCTTAAATAGCTAT TCATATTTTTAAGGTGTTTCATCCAGAGGAATTTTAATGTGCCTGTAAATGTTCCATAGAACCACAACCATCAAAAAGAGTTGTTTTATTTTTACATAGTTCATTATATGTACATGTATATATGTCTA TATGTATATGGCCGTGTATATACATATATATGTATACACACATGCATACATATGCACACACAGACCATCACATGCTCAGAGTCCTGACAGCATGACTATAACATTTTTTTAATAAGTGTCCTTTGGTA AAAAAAAATATATATACATATATATATATATCTCCTATCAGTCCTTTCTAAGAAACCCAAACTACCAAAAACCACCCCCACGGCCACTTTCTGAAGTTGGTTCTGCTTTTTTTTCCCTGCAGTATTGT TTAGCCATCTTCTGCTCTTGGTAAGGTTGACATAGTGTATGTCAATTAAAAAACAACAACAGCAACAAAGTCTGCTTTGTAAATAGTAATTTTACCCAGTGGTGCATGTTTGAGCAAATGAAAATGAT TTAAGCACAGTATTTACTGCATCAAATATGTACCACAGTTAAGTATAGTTTGCAAGCTTTCAACAGGCGACATGGTGTCACTGGGTCCCTTAGAGTTTGAAGCTGTCACCGCTGCATGTCTCTCTTGC TGATGCCGCTGTATCTTAACCCTTCTGCTGTTCAGAAGTCTAACAGGGAAGCCATACGTCGGTGGCGAAGTGAAGCAAATCGGTCCACCAGGAACTCACTCTTCGTGACATGAGCCATGGGTTGCGGT AAACGGGAAGGAGATCCTTGTTCTTGGTTCTCCCAAACCTTAATGGAACAGCCGGTGAGATGTCTGACAGTGTAAGCTGCTTAGATCTGTTAAAAGTATGTGCTTCGAGTTTTCTAAGGAAATATACA TATTGTAAAAAAGGGGGGGCTCATTTTATTTTATTTCAAAGCCTTTTGTACATAAAATGGGAAATTAAAAGTATCTTCAGGTTGACGTCACAGTTCTACCGTTAGTTTCTGTTCCCCGGCACTTTTTA ATCAAGGCACTTCGTCACGGAAGAGATAAGGCCTAAGAGGCAGTGTAGGGCTCTGGCTGTCGTTGTTGGTACTGTGGACTTGCGCGTATTTCCACTTGAAACAATTCTCATTCCAAGTCTAATGTCCA TTTGCTTTCAATAGTGATGCCTTATCATTGACAAGAGATTTCAAGGGGAGCAGATGACACTCTTGGCATTGCCTGAGTAGGATGTCCTCACCTAGTGTTTCTCCTCTACTCATCCATCTTTTTTAATG TTCGTTTACACAGATAGATAGATGGATAGATAGAATCTTACTCATCCACATGGCACCAGAGCTGTTTCAGGTATGATTCGGGAACCAAGCGCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTCTC TCTCTCTCTCTCTCTCTCTCTGTTTTCCACAAAACCAGTTAGTGAAATGATATCGCCAATTACAGCCAAACACTTTGTTTCACAGACAACCTTCAATGTAGATTCTTTATACTAAAGCTGTTGACTTG TAGCGTGTTCATGAATGCATGCAGGAAAATGCTATTACCATACAGAGCTACCGGTAAGCCACATTACGATCAAGCCAAAAGAATAAAGATTTTTTTTTTTGCTTT
hide sequence
RefSeq Acc Id:
XM_063283105 ⟹ XP_063139175
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 70,710,875 - 70,845,569 (+) NCBI
RefSeq Acc Id:
XM_063283106 ⟹ XP_063139176
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 70,710,862 - 70,845,569 (+) NCBI
RefSeq Acc Id:
XM_063283107 ⟹ XP_063139177
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 70,759,048 - 70,845,569 (+) NCBI
RefSeq Acc Id:
NP_036779 ⟸ NM_012647
- UniProtKB:
A0A8I5YBA6 (UniProtKB/TrEMBL), A6HLX5 (UniProtKB/TrEMBL)
- Sequence:
MARSVLVPPGPDSFRFFTRESLAAIEQRIAEEKAKRPKQERKDEDDENGPKPNSDLEAGKSLPFIYGDIPPEMVSEPLEDLDPYYINKKTFIVLNKGKAISRFSATSALYILTPFNPIRKLAIKILVH SLFNVLIMCTILTNCVFMTMSNPPDWTKNVEYTFTGIYTFESLIKILARGFCLEDFTFLRNPWNWLDFTVITFAYVTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMILTV FCLSVFALIGLQLFMGNLRNKCLQWPPDNSTFEINITSFFNNSLDWNGTAFNRTVNMFNWDEYIEDKSHFYFLEGQNDALLCGNSSDAGQCPEGYICVKAGRNPNYGYTSFDTFSWAFLSLFRLMTQD FWENLYQLTLRAAGKTYMIFFVLVIFLGSFYLINLILAVVAMAYEEQNQATLEEAEQKEAEFQQMLEQLKKQQEEAQAAAAAASAESRDFSGAGGIGVFSESSSVASKLSSKSEKELKNRRKKKKQKE QAGEEEKEDAVRKSASEDSIRKKGFQFSLEGSRLTYEKRFSSPHQSLLSIRGSLFSPRRNSRASLFNFKGRVKDIGSENDFADDEHSTFEDNDSRRDSLFVPHRHGERRPSNVSQASRASRGIPTLPM NGKMHSAVDCNGVVSLVGGPSALTSPVGQLLPEGTTTETEIRKRRSSSYHVSMDLLEDPSRQRAMSMASILTNTMEELEESRQKCPPCWYKFANMCLIWDCCKPWLKVKHVVNLVVMDPFVDLAITIC IVLNTLFMAMEHYPMTEQFSSVLSVGNLVFTGIFTAEMFLKIIAMDPYYYFQEGWNIFDGFIVSLSLMELGLANVEGLSVLRSFRLLRVFKLAKSWPTLNMLIKIIGNSVGALGNLTLVLAIIVFIFA VVGMQLFGKSYKECVCKISNDCELPRWHMHHFFHSFLIVFRVLCGEWIETMWDCMEVAGQTMCLTVFMMVMVIGNLVVLNLFLALLLSSFSSDNLAATDDDNEMNNLQIAVGRMQKGIDFVKRKIREF IQKAFVRKQKALDEIKPLEDLNNKKDSCISNHTTIEIGKDLNYLKDGNGTTSGIGSSVEKYVVDESDYMSFINNPSLTVTVPIALGESDFENLNTEEFSSESDMEESKEKLNATSSSEGSTVDIGAPA EGEQPEAEPEESLEPEACFTEDCVRKFKCCQISIEEGKGKLWWNLRKTCYKIVEHNWFETFIVFMILLSSGALAFEDIYIEQRKTIKTMLEYADKVFTYIFILEMLLKWVAYGFQMYFTNAWCWLDFL IVDVSLVSLTANALGYSELGAIKSLRTLRALRPLRALSRFEGMRVVVNALLGAIPSIMNVLLVCLIFWLIFSIMGVNLFAGKFYHCINYTTGEMFDVSVVNNYSECQALIESNQTARWKNVKVNFDNV GLGYLSLLQVATFKGWMDIMYAAVDSRNVELQPKYEDNLYMYLYFVIFIIFGSFFTLNLFIGVIIDNFNQQKKKFGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPANKFQGMVFDFVTKQVFDIS IMILICLNMVTMMVETDDQSQEMTNILYWINLVFIVLFTGECVLKLISLRHYYFTIGWNIFDFVVVILSIVGMFLAELIEKYFVSPTLFRVIRLARIGRILRLIKGAKGIRTLLFALMMSLPALFNIG LLLFLVMFIYAIFGMSNFAYVKREVGIDDMFNFETFGNSMICLFQITTSAGWDGLLAPILNSGPPDCDPEKDHPGSSVKGDCGNPSVGIFFFVSYIIISFLVVVNMYIAVILENFSVATEESAEPLSE DDFEMFYEVWEKFDPDATQFIEFCKLSDFAAALDPPLLIAKPNKVQLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDALRIQMEERFMASNPSKVSYEPITTTLKRKQEEVSAIVIQRAYRRYL LKQKVKKVSSIYKKDKGKEDEGTPIKEDIITDKLNENSTPEKTDVTPSTTSPPSYDSVTKPEKEKFEKDKSEKEDKGKDIRESKK
hide sequence
Ensembl Acc Id:
ENSRNOP00000072059 ⟸ ENSRNOT00000087242
Ensembl Acc Id:
ENSRNOP00000007069 ⟸ ENSRNOT00000007069
Ensembl Acc Id:
ENSRNOP00000095098 ⟸ ENSRNOT00000108259
Ensembl Acc Id:
ENSRNOP00000087779 ⟸ ENSRNOT00000118742
Ensembl Acc Id:
ENSRNOP00000076431 ⟸ ENSRNOT00000098856
RefSeq Acc Id:
XP_063139176 ⟸ XM_063283106
- Peptide Label:
isoform X2
- UniProtKB:
A0A0G2K207 (UniProtKB/TrEMBL), A6HLX5 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063139175 ⟸ XM_063283105
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I5YBA6 (UniProtKB/TrEMBL), A6HLX5 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063139177 ⟸ XM_063283107
- Peptide Label:
isoform X2
- UniProtKB:
A0A0G2K207 (UniProtKB/TrEMBL), A6HLX5 (UniProtKB/TrEMBL)
RGD ID: 13692106
Promoter ID: EPDNEW_R2629
Type: single initiation site
Name: Scn2a_1
Description: sodium voltage-gated channel alpha subunit 2
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 3 51,687,836 - 51,687,896 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-02-11
Scn2a
sodium voltage-gated channel alpha subunit 2
Scn2a
sodium channel, voltage-gated, type II, alpha subunit
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2014-08-13
Scn2a
sodium channel, voltage-gated, type II, alpha subunit
Scn2a1
sodium channel, voltage-gated, type II, alpha 1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-03-31
Scn2a1
sodium channel, voltage-gated, type II, alpha 1
Scn2a1
sodium channel, voltage-gated, type 2, alpha 1 subunit
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-03-20
Scn2a1
sodium channel, voltage-gated, type 2, alpha 1 subunit
Scn2a1
sodium channel, voltage-gated, type 2, alpha 1 polypeptide
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2002-06-10
Scn2a1
sodium channel, voltage-gated, type 2, alpha 1 polypeptide
Name updated
70585
PROVISIONAL
Note Type
Note
Reference
gene_process
responsible for generation and propagation of action potentials, chiefly in nerve and muscle
68844